Radiomics-based tumor heterogeneity augments clinicopathological models for predicting recurrence in high-risk clear cell renal cell carcinoma after nephrectomy
Open Access
- 12 July 2025
- journal article
- research article
- Published by Springer Nature in Abdominal Radiology
- Vol. 51 (2) , 878-888
Abstract
Purpose: To investigate the association between CT radiomics-based tumor heterogeneity and recurrence-free survival (RFS) in high-risk clear cell renal cell carcinoma (ccRCC) after nephrectomy, and to determine whether integrating CT radiomics with clinicopathological model enhances recurrence risk prediction for adjuvant treatment decisions. Methods: This retrospective study included 194 patients with high-risk ccRCC undergoing nephrectomy. A radiomics model based on random survival forest was developed in the training set, using radiomics features extracted from pre-operative corticomedullary phase images. The performance of radiomics, Leibovich score, and the combined model were evaluated using Kaplan-Meier survival analysis, time-dependent receiver operating characteristic curves (time-AUC), time-dependent Brier scores, and decision curve analysis in external test set. Results: During follow-up, 62 patients experienced recurrence. The radiomics model demonstrated superior predictive performance compared to the Leibovich score, with higher time-dependent AUCs (1-year: 0.882 vs. 0.781; 2-year: 0.865 vs. 0.762; 3-year: 0.793 vs. 0.797; all p < 0.05) and better calibration (lower Brier scores) in the test set. Decision curve analysis demonstrated that the combined model provided the highest net benefit, particularly for 2- to 3-year recurrence risk predictions. Conclusions: For high-risk ccRCC, CT radiomics provides incremental prognostic value beyond conventional clinicopathological models, enabling more precise recurrence risk stratification. This approach bridges imaging and precision oncology, with potential to optimize surveillance protocols and adjuvant therapy trial design.Keywords
Funding Information
- Zhejiang Provincial Natural Science Foundation of China (LTGY24H180003)
- General Project of Hangzhou Health Science and Technology Program (B20253445)
This publication has 32 references indexed in Scilit:
- Sub-regional Radiomics Analysis for Predicting Metastasis Risk in Clear Cell Renal Cell Carcinoma: A Multicenter Retrospective StudyAcademic Radiology, 2024
- Predicting the recurrence risk of renal cell carcinoma after nephrectomy: potential role of CT-radiomics for adjuvant treatment decisionsEuropean Radiology, 2023
- Decision curve analysis in the evaluation of radiology researchEuropean Radiology, 2022
- The radiomics-based tumor heterogeneity adds incremental value to the existing prognostic models for predicting outcome in localized clear cell renal cell carcinoma: a multicenter studyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2022
- Overall Survival Prediction in Renal Cell Carcinoma Patients Using Computed Tomography Radiomic and Clinical InformationJournal of Digital Imaging, 2021
- Radiomics-based machine learning model to predict risk of death within 5-years in clear cell renal cell carcinoma patientsComputers in Biology and Medicine, 2021
- Radiomics of computed tomography and magnetic resonance imaging in renal cell carcinoma—a systematic review and meta-analysisEuropean Radiology, 2020
- Predicting the ISUP grade of clear cell renal cell carcinoma with multiparametric MR and multiphase CT radiomicsEuropean Radiology, 2020
- Renal cell carcinoma recurrences and metastases in primary non-metastatic patients: a population-based studyWorld Journal of Urology, 2016
- Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinomaCancer, 2003